Scotland · NHS Scotland MSAN
Champix® (varenicline) 0.5mg and 1mg tablets
MSAN(2021)33 · Level 3 · issued 09 Nov 2021
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| effective options are available. | Available | — |
| doctor or pharmacist, as the health risk of discontinuing the medicine is higher than the | Discontinued | — |
| discontinuation of Champix® (varenicline) tablets. | Discontinued | — |
| prevent symptoms of tobacco withdrawal following discontinuation of Champix® | Discontinued | — |
| o As varenicline is a non-nicotine treatment, after discontinuation of varenicline it may | Discontinued | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2021:33
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
08ddb988717226369b14225f0107689c241e4dcf01a9ac6f9ac1048f90d9ef61sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2021-33.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.